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Abstract
Objective A small proportion of the population accounts for the majority of healthcare costs. Mental health and addiction (MHA)
patients are consistently high-cost. We aimed to delineate factors amenable to public health action that may reduce high-cost use
among a cohort of MHA clients in Saskatoon, Saskatchewan.
Methods We conducted a population-based retrospective cohort study. Administrative health data from fiscal years (FY) 2009–
2015, linked at the individual level, were analyzed (n = 129,932). The outcome of interest was ≥ 90th percentile of costs for each
year under study (‘persistent high-cost use’). Descriptive analyses were followed by logistic regression modelling; the latter
excluded long-term care residents.
Results The average healthcare cost among study cohort members in FY 2009 was ~ $2300; for high-cost users it was ~ $19,000.
Individuals with unstable housing and hospitalization(s) had increased risk of persistent high-cost use; both of these effects were
more pronounced as comorbidities increased. Patients with schizophrenia, particularly those under 50 years old, had increased
probability of persistent high-cost use. The probability of persistent high-cost use decreased with good connection to a primary
care provider; this effect was more pronounced as the number of mental health conditions increased.
Conclusion Despite constituting only 5% of the study cohort, persistent high-cost MHA clients (n = 6455) accounted for ~ 35%
of total costs. Efforts to reduce high-cost use should focus on reduction of multimorbidity, connection to a primary care provider
(particularly for those with more than one MHA), young patients with schizophrenia, and adequately addressing housing
stability.
Résumé
Objectif Une faible proportion de la population compte pour la majorité des coûts des soins de santé. Les patients en santé
mentale et en toxicomanie (SMT) engendrent systématiquement des coûts élevés. Nous avons cherché à délimiter les facteurs qui
se prêteraient à des mesures de santé publique susceptibles de réduire l’utilisation à coût élevé dans une cohorte d’usagers en
SMT de Saskatoon (Saskatchewan).
Electronic supplementary material The online version of this article
(https://doi.org/10.17269/s41997-018-0101-2) contains supplementary
material, which is available to authorized users.
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Méthode Nous avons mené une étude de cohorte populationnelle rétrospective. Les données administratives sur la santé des
exercices 2009 à 2015, jumelées au niveau individuel, ont été analysées (n = 129 932). Le résultat qui nous intéressait était ≥ au
90e centile des coûts pour chaque exercice à l’étude (« utilisation à coût élevé persistante »). Des analyses descriptives ont été
suivies par des modèles de régression logistique; ces derniers ont exclu les résidents en soins de longue durée.
Résultats Le coût moyen des soins de santé chez les membres de la cohorte étudiée était d’environ 2300 $ durant l’exercice 2009;
pour les utilisateurs à coût élevé, il était d’environ 19 000 $. Les personnes vivant dans des conditions de logement précaires et
ayant été hospitalisées une ou plusieurs fois présentaient un risque accru d’utilisation à coût élevé persistante; les deux effets
s’accentuaient avec la présence de comorbidités. Les patients schizophrènes, surtout ceux de moins de 50 ans, présentaient une
probabilité accrue d’utilisation à coût élevé persistante. La probabilité d’utilisation à coût élevé persistante diminuait avec la
qualité du lien vers un dispensateur de soins primaires; cet effet s’accentuait avec l’augmentation du nombre de troubles de santé
mentale.
Conclusion Bien qu’ils n’aient constitué que 5 % de la cohorte à l’étude, les usagers en SMT faisant une utilisation à coût élevé
persistante des soins de santé (n = 6455) comptaient pour ~ 35 % des coûts totaux. Les efforts pour réduire l’utilisation à coût
élevé devraient se concentrer sur la réduction des comorbidités, sur le lien vers un dispensateur de soins primaires (surtout pour
les patients présentant plus d’un problème de SMT) et sur les jeunes patients schizophrènes, et ils devraient suffisamment tenir
compte de la précarité du logement.
Keywords Mental health and addictions . High-cost users . Social determinants of health
Mots-clés Santé mentale et toxicomanie . Usagers à coût élevé . Déterminants sociaux de la santé
Introduction
Evidence has long demonstrated that a small proportion of the
population (< 10%) accounts for the majority (50–70%) of
total healthcare spending (Densen et al. 1959): individuals
commonly referred to as ‘high-cost users’. As early as 1988,
Taube et al. demonstrated that individuals with mental disor-
ders comprised 9% of high-cost users in 1 year (i.e., those with
≥ 25 visits), but accounted for nearly half (49.2%) of total
outpatient expense (Taube et al. 1988). In a Medicaid popula-
tion study of high-cost users, Buck et al. (2003) showed that
people using mental health and substance abuse services con-
stituted 11% of all enrollees but accounted for approximately
30% of all high-cost users (Buck et al. 2003). Hunter et al.
(2015) found that nearly half of high-cost users had a mental
health condition (Hunter et al. 2015).
Three Canadian studies have focused on patients with high
costs and mental health and addiction (MHA) issues. de
Oliveira et al. demonstrated that high-cost MHA patients incur
30% more healthcare costs per capita compared to high-cost
users with no mental health conditions (de Oliveira et al.
2016b); a subsequent study demonstrated that MHA high-
cost patients (‘MHA high-cost’ patients defined as individuals
for whom MHA services accounted for ≥ 50% of their total
healthcare costs) had healthcare costs 40% higher than those
with no MHA-related costs (de Oliveira et al. 2017a). Using a
combination of mood, substance use, psychotic and anxiety
disorders as the definition of mental illness, Hensel et al.
found that rates of mental illness were 39.3% in the top 1%
costliest users (compared to 21.3% in the lowest cost group)
(Hensel et al. 2016).
The disease burden of mental health and addiction disor-
ders is large; it is estimated that in any given year, one in five
Canadians will experience a mental illness or addiction, and,
by age 40, one in two will have, or have had, a mental illness
(Lim et al. 2008; Ratnasingham et al. 2013; Smetanin et al.
2011).
Mental health and addiction patients can have complex
care needs related to their illness, as well as deficits in their
social determinants of health, such as housing, income, edu-
cation and employment (Walker and Druss 2016). Among
MHA high-cost users, persons diagnosed with schizophrenia
are more often high-cost, largely driven by hospitalizations
(de Oliveira et al. 2016a; Fortney et al. 2009; Hensel et al.
2016; Junghan and Brenner 2006; Robst 2012). Stable hous-
ing, particularly, has been demonstrated to not only decrease
healthcare service use, which is directly related to cost, but
also improve health outcomes overall for mental health and
addiction patients (Charkhchi et al. 2018; Fitzpatrick-Lewis et
al. 2011; Hwang et al. 2005; Kerman et al. 2018; Rog et al.
2014; Stergiopoulos et al. 2018). Recent studies demonstrated
residential instability as a risk factor for high-cost healthcare
use at an ecological level (Thavorn et al. 2017) in addition to
psychiatric inpatient cost savings (Rudoler et al. 2018). Given
these previous findings, the current study included an admin-
istrative database definition of unstable housing in order to
understand this covariate at an individual level in the study
population.
Using population-based administrative health databases,
we conducted an exploratory study to delineate factors ame-
nable to public health action to prevent persistent high-cost
use among a cohort of mental health and addiction clients in
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Saskatoon, Saskatchewan, Canada. We included healthcare
utilization/access measures, such as connection to a primary
care provider, and social determinants of health measures,
such as unstable housing. The large cohort under study makes
use of individual-level data, as opposed to previous studies
(Thavorn et al. 2017) which rely on neighbourhood/
ecological predictors.
Methods
Saskatchewan (population ~ 1.2 million) is a Canadian prov-
ince with a central provincial health insurer. Health data are
captured for the provincial population with the exception of
residents covered under the federal government (~ 1%), spe-
cifically inmates of federal prisons, members of the Royal
CanadianMounted Police (prior to 2013), Indigenous persons
receiving primary healthcare services on federal reserve, and
Canadian Armed Forces (Downey et al. 2006). The study
population, due to database availability, was limited to
Saskatoon Health Region, the largest health region in the
province (n = 360,000).
Databases Detailed descriptions of Saskatchewan administra-
tive health databases are available elsewhere (Downey et al.
2006). All data were linked at the individual level using the
same unique encrypted identifier. Demographic characteris-
tics, location of residence and insurance coverage were ex-
tracted from the Personal Health Registration System
(PHRS). Hospital data for the province of Saskatchewan,
and submitted to the Canadian Institute for Health
Information (CIHI), were extracted from the Discharge
Abstract Database (DAD) and include all hospitalizations (in-
cluding psychiatric hospitalizations) in the province. The
International Classification of Diseases (ICD), 10th revision,
Canadian Version (ICD-10-CA) was used in the DAD to re-
cord up to 25 diagnoses at admission, including the most
responsible one. Data on physician services are contained in
the Medical Services Database. Physicians paid on a fee-for-
service basis submit billing claims to the provincial health
ministry; a single diagnosis using a three-digit ICD-9 code is
recorded on each claim. Salaried physicians are required to
submit ‘dummy’ claims for administrative purposes (shadow
billing) but compliance is low; therefore, a level of under-
reporting for salaried physician claims will exist. According
to a recent CIHI report, a ‘relatively small percentage of
Saskatchewan physicians are compensated through salaried
arrangements’ (Canadian Institute for Health Information
2008). Residents of long-term care facilities were defined ac-
cording to the provincial Resident Assessment Instrument-
Minimum Dataset (RAI-MDS) for long-term care facilities
(RAI-LTC 2.0). The following datasets were available for
Saskatoon Health Region only (n = 162,566 individuals):
emergency department data recorded in National
Ambulatory Care Reporting System (NACRS); the Shared
Client Index (SCI), an identity management system used to
manage patient contact information; and the Population and
Public Health, Saskatoon Health Region, Street Outreach
Database. A combination of frequent address changes in the
Shared Client Index and individuals in the Street Outreach
Database permitted an administrative database definition of
‘unstable housing’. Total government healthcare costs by pub-
licly funded source (hospital, physician, prescription drug and
long-term care) were provided by the Saskatchewan Ministry
of Health. Data were linked at the individual level using a
unique non-identifiable health services number generated by
eHealth Saskatchewan.
Study design We conducted a retrospective population-based
study using administrative health data. The study population
included any individual with continuous provincial insurance
coverage, resident of Saskatoon Health Region, ≥ 18 years
old, alive as of April 1, 2009 (study baseline) and with at least
one mental health or addiction-related International
Classification of Disease Codes (ICD-9 or ICD-10) diagnosis
in any database from April 1, 2003, to March 31, 2015, with
the exception of dementia and dementia-related codes (Table
S1). Total healthcare costs were calculated by unique individ-
ual for each fiscal year 2009–2015.
Exposure Using a combination of emergency department,
physician and hospital data, mental health and addiction
ICD-10 codes were grouped into the following: substance-
related disorders; schizophrenia, delusional and non-organic
psychotic disorders; mood/affective disorders; anxiety disor-
ders; and selected disorders of adult personality and behaviour
(Table S1).
Outcome The primary end-point was persistent high-cost
healthcare use (≥ 90th percentile for each fiscal year 2009 to
2015). Using the costing methodology developed byWodchis
et al., all costs were estimated and assigned to unique study
individuals (Wodchis et al. 2013). Briefly, this methodology
provides guidance on how to identify unit costs associated
with individual healthcare utilization and how to combine
these with utilization data from administrative databases, pro-
viding a measure of direct healthcare costs incurred by gov-
ernment. To account for death during the study period, each
study subject’s total healthcare costs were divided by total
number of days observed in the study.
High-cost status among cohort members was determined
for each year of the study period using population proportional
thresholds (Wodchis et al. 2016). As cost was shown to vary by
individual over time, variables of ‘never high-cost’ (never ≥
90th percentile for any year of the study period), ‘sometimes
high cost’ (≥ 90th percentile in any one year) and ‘persistent
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high-cost’ (≥ 90th percentile for all years, including up to the
point of death) were calculated. Total costs were a sum of
mutually exclusive government costs for hospitalizations,
prescription drugs, emergency department visits, physician
services, and long-term care. Physician billing and prescrip-
tion drug costs were direct totals payable by the provincial
health insurer. Hospitalization costs were obtained using the
Standard Cost of a Hospital Stay multiplied by the specific
resource intensity weight (RIW) at the individual-level
(Canadian Institute for Health Information (CIHI) 2015a,
b). Long-term care (LTC) costs were defined using the actual
government LTC expenditure provided by the Community
Care Branch, Saskatchewan Ministry of Health, and calculat-
ed as a daily cost per bed. This cost was multiplied by the
number of days an individual was resident in LTC. Study
cohort costs were further defined as an annual weighted cost,
weighted based on the number of days the individual was
alive per study year. All yearly costs were adjusted for infla-
tion to FY 2015.
Covariates Variables included were as follows: age, sex,
urban/rural location of residence, neighbourhood-level in-
come quintile, death, number of mental health conditions,
comorbid conditions, Usual Provider Continuity (UPC) index,
unstable housing, and healthcare utilization measures. All co-
variates were defined at the point of occurrence (such as
death), otherwise, as of study baseline April 1, 2009, permit-
ting a temporal association between exposures (covariates)
and persistent high-cost use (outcome).
The UPC index developed by CIHI was used to indicate
the degree to which an individual is connected to a primary
care provider. Each physician in the province is assigned a
unique number. The UPC is a proportion—for each study
cohort member, the total number of physician visits to the
same general practitioners’ number is divided by the total
number of physician visits to all general practitioners over
the same time period. For regression modelling, a dichoto-
mous variable of the UPC index score was created using
CIHI’s categorization of 0 to < 0.75 (poorly connected) versus
0.75+ (well connected) (Canadian Institute for Health
Information 2016).
Neighbourhood-level income quintile was based on dis-
semination area average household income values from
public-use Statistics Canada census files using the postal code
methodology developed by the Institut National de Santé
Publique du Québec (INSPQ 2007). As hospital stays are
known to drive healthcare costs, ‘hospitalization’ was defined
as ever having an acute in-patient stay prior to the costing
observation period. Unstable housing was defined as street
involvement (street outreach client, n = 967), or ≥ 4 address
changes in a 12-month period from 2003 to 2009 (n = 299).
All hospitalizations, emergency department and physician
visits (specialty and general practice) from April 1, 2003, to
March 31, 2009, were summed bymental health and addiction
diagnostic category. As a large proportion of the study cohort
had more than one mental health condition (37%), ‘primary
mental health condition’ was assigned as the most frequent
MHA diagnostic code(s) across physician, hospitalization
and emergency department in the study period.
Comorbidities were defined using validated case defini-
tions for chronic disease conditions from the Canadian
Chronic Disease Surveillance System (CCDSS): (1) chronic
obstructive pulmonary disease (COPD), (2) congestive heart
failure (CHF), (3) asthma, (4) diabetes, and (5) coronary artery
disease (CAD) (Public Health Agency of Canada 2003; Feely
et al. 2017). For regression modelling, the total number of
comorbid conditions was used (0 to 5). Death data were ob-
tained using a ‘verified death file’ (combination of death data
from various administrative health databases) created by the
Saskatchewan Health Quality Council for research purposes.
Statistical analyses Following univariate and bivariate analy-
ses, multivariate regression modelling was used to delineate
factors associated with persistent high-cost use. Classification
and regression tree (CART) modelling facilitated a visual un-
derstanding of variables contributing most to persistent high-
cost use; subsequent logistic regressionmodelling, probit link,
quantified the relationship between persistent high-cost use
and significant co-variates. In logistic modelling, missing
values (income quintile and location of residence) were coded
as ‘missing’. Sensitivity analyses with and without missing
data were conducted.
All long-term care residents (n = 5435; 4.2% of cohort)
were excluded from the logistic modelling. Approximately
36% of persistent high-cost users were residents of a LTC
facility. As we aimed to delineate factors amenable to public
health action to prevent persistent high-cost use, it was con-
sidered reasonable to exclude these study subjects. It was as-
sumed that individuals in LTC facilities met the standardized
criteria for requiring their higher level of care and their reason
for persistent high-cost use was known.
All analyses were conducted using SAS©Enterprise Guide
version 7.1 (SAS Institute Inc. 2017).
The study proposal underwent ethical review and approval
by the University of Saskatchewan Biomedical Research
Ethics Board, the University of Prince Edward Island
Research Ethics Board and the Health Canada/Public Health
Agency of Canada Research Ethics Board for research involv-
ing humans.
Results
A total of 129,932 unique individuals eligible for provincial
health insurance, resident of Saskatoon Health Region (SHR)
and alive as of the study baseline date (April 1, 2009) were
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identified as belonging to the study cohort (Fig. 1). Of these,
the majority (55%) were ‘never high-cost’; persistent high-
cost users accounted for 5% of the study cohort. Cohort char-
acteristics at study baseline are detailed in Table 1.
Compared to never high-cost, persistent high-cost users had
higher proportions of females, schizophrenia diagnosis, unsta-
ble housing, and deaths. Approximately 30% of high-cost
users in FY 2009 went on to be high-cost in subsequent years
(data not shown). Persistent high-cost users were less likely to
have a primary mental health diagnosis of anxiety and more
likely to have a diagnosis of schizophrenia, delusional and
non-organic psychotic disorders (Table 1). Individuals with a
primary mental health condition of schizophrenia had total
healthcare costs ~ five times higher, and nearly twice the av-
erage number of hospitalizations and physician visits, com-
pared to all other MHA diagnoses (Table 2).
Despite comprising only 5% of the population, persistent
high-cost users (n = 6455) accounted for nearly 35% of total
costs (FY 2009). Never high-cost users (n = 71,834)
accounted for over half of the study population but less than
10% of costs; sometimes high-cost users (n = 51,643)
accounted for approximately 40% of the study population
and 57% of the costs (Fig. 2).
Multivariable logistic regression identified predictors sta-
tistically significantly associated with persistent high-cost use.
Compared to the logit link, a probit link provided a better
fitting model, common in studies using healthcare cost as an
outcome and susceptible to heteroscedasticity (Basu et al.
2006). Relevant two-way interactions and one three-way in-
teraction term were retained in the final model as they im-
proved model performance. Age, sex, and primary mental
health condition interacted (p = 0.005); patients with schizo-
phrenia, particularly those under 50 years old, had increased
probability of persistent high-cost use; females with anxiety
had higher probability of persistent high-cost use compared to
males. Neighbourhood-level income quintile, when taken into
account with all other predictors, was not statistically signifi-
cantly associated with persistent high-cost use (p = 0.3).
Several covariates (connection to a primary care provider,
number of mental health conditions, number of comorbid con-
ditions) interacted with ‘died during study period’. All inter-
action terms demonstrated increased risk for persistent high-
cost use when study subjects died during the observation pe-
riod. This occurred despite accounting for number of days
alive in the study period when assigning costs and excluding
long-term care residents in the modelling. Sensitivity analyses
including and excluding patients who died during the study
period did not differ in overall findings/conclusion.
A number of statistically significant two-way interactions
occurred. Connection to a primary care provider was protective
of persistent high-cost use in general, but particularly for indi-
viduals with multiple mental health conditions (p = 0.001).
Unstable housing increased the probability of persistent high-
cost use in general, but this effect was more pronounced with
2+ comorbid conditions (p = 0.02). Similarly, hospitalization
increased the probability of persistent high-cost use, but par-
ticularly for those with two or more comorbidities (p = 0.01)
(Table 3). The model showed evidence of good fit.
All pairwise comparisons in interaction terms were adjusted
for multiple comparisons (Bonferroni’s method) (Table S2).
Discussion
Average healthcare costs among study cohort members in FY
2009 were approximately $2300; those among high-cost users
Exclude residents outside of Saskatoon 
Health Region (study population) as of April 
1st 2009 (study baseline) 
n = 162,566 
Exclude those who died prior to April 1st 2009 
n = 138,257 
Exclude those ineligible for provincial health 
insurance and/or with greater than a 3 day gap 
in continuous health coverage 
n = 129,932 
Population of Saskatchewan, Canada 
n = ~1.2 million  
Eligible study population: unique persons, >=18 years, 
with at least one mental health and addictions ICD-code, 
excluding dementia, in administrative health databases 
(physician billing, hospitalization, and/or emergency 
department) April 1st, 2003 to March 31st, 2015  
n = 451,674 
Exclude long-term care residents 
(regression modelling only) 
n = 124,497 
Fig. 1 Study cohort inclusion/exclusion criteria
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Table 1 Descriptive statistics,
mental health and addiction study
cohort, Saskatoon Health Region,
Saskatchewan (n = 129,932)
Covariates (n) (%)/(mean) (SD) Never high-cost
n = 71,834
n (%) or mean (SD)
Sometimes high-cost
n = 51,643
n (%) or mean (SD)
Persistent high-cost
n = 6455
n (%) or mean (SD)
Mean age, years (SD) 42 (15) 51 (19) 68 (17)
Sex
Female (57%) 37,599 (52%) 33,020 (64%) 3639 (56%)
Male (43%) 34,235 (48%) 18,623 (36%) 2816 (44%)
Location of residence
Urban (84%) 60,668 (85%) 42,799 (83%) 5363 (83%)
Rural (15%) 10,285 (14%) 8281 (16%) 1050 (16%)
Missing* (1%) 881 (1%) 563 (1%) 42 (1%)
Primary mental health diagnosis
Substance-related disorders (15%) 11,458 (16%) 7067 (14%) 676 (10%)
Schizophrenic disorders (5%) 1025 (1%) 3126 (6%) 1707 (26%)
Mood/affective disorders (27%) 19,594 (27%) 15,376 (30%) 1810 (28%)
Anxiety disorders (52%) 39,524 (55%) 25,928 (50%) 2235 (35%)
Disorders of adult personality (1%) 233 (1%) 146 (1%) 27 (1%)
Number of mental health
conditions (mean; SD)
1.4 (0.6) 1.6 (0.8) 2.0 (1.0)
Physician visits per year (mean; SD) 5.5 (5.4) 10.2 (8.6) 24.7 (18.2)
Emergency department visits
per year (mean; SD)
0.2 (0.4) 0.4 (0.9) 1.1 (2.1)
Number of hospitalizations
per year (mean; SD)
0.1 (0.2) 0.3 (0.3) 0.7 (0.9)
At least 1 psychiatrist visit (16%) 9222 (13%) 8806 (17%) 2294 (36%)
Mean healthcare cost per year ($; SD) $557 ($745) $3242 ($7467) $28,320 ($35,003)
Income quintile
1 (least affluent) (20%) 13,799 (19%) 11,180 (22%) 1587 (25%)
2 (18%) 12,633 (18%) 9033 (18%) 1165 (18%)
3 (20%) 14,456 (20%) 10,260 (20%) 1263 (20%)
4 (18%) 12,927 (18%) 9012 (17%) 1013 (16%)
5 (most affluent) (18%) 13,113 (18%) 8833 (17%) 1028 (16%)
Missing* (6%) 4906 (7%) 3325 (6%) 399 (5%)
Unstable housing (1%) 412 (1%) 691 (1%) 163 (3%)
Connection to primary care doctor
Well connected (43%) 27,196 (38%) 25,202 (49%) 3056 (47%)
Not well connected (57%) 44,638 (62%) 26,441 (51%) 3399 (53%)
Select comorbid conditions
Diabetes (12%) 4267 (6%) 8635 (17%) 2562 (40%)
Chronic obstructive pulmonary
disease (9%)
3067 (4%) 6662 (13%) 2147 (33%)
Congestive heart failure (7%) 905 (1%) 5484 (11%) 2645 (41%)
Coronary artery disease (11%) 2346 (3%) 9535 (19%) 2843 (44%)
Asthma (9%) 4990 (7%) 5508 (11%) 1097 (17%)
Died during study period
(FY 2009–2015) (7%)
686 (1.0%) 4249 (8%) 3515 (55%)
Long-term care resident
Yes** (4%) 13 (0.02%) 3074 (6%) 2348 (36%)
No (96%) 71,821 (99.8%) 48,569 (94%) 4107 (64%)
*Modelled categorically as ‘missing’ in regression modelling
**Excluded from regression modelling
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were nearly $19,000. Despite making up less than 5% of the
study population, persistent high-cost mental health and addic-
tion clients in SHR accounted for nearly 35% of total SHR
costs. In multivariable logistic regression, even after accounting
for other potentially confounding factors, unstable housing was
found to increase the probability of persistent high-cost use in
the study population; a higher probability occurred if the indi-
vidual had other underlying health conditions. A recent study in
Ontario by Thavorn et al. similarly demonstrated, at an ecologic
level, the association between residential instability and
multimorbidity in high costs (Thavorn et al. 2017).
Homelessness is known to be associated with increased
healthcare utilization, poor health status, health inequities,
and mental health conditions (Aldridge and Kelley 2015).
The complexities of co-occurrence of mental illness, chronic
medical conditions, and housing status need to be taken into
account when conceptualizing and addressing multimorbidity
(Walker and Druss 2016). Individuals with complex MHA
issues may cope with co-existing conditions (such as diabetes
or heart disease) less well than individuals without mental
illness (Prior et al. 2018). The positive effects of stable hous-
ing on health outcomes have been well documented—
resulting in fewer communicable diseases, injuries, better
chronic disease management/prevention, and improved
psycho-social well-being (Fitzpatrick-Lewis et al. 2011).
Policy makers, concerned with healthcare cost contain-
ment, are reasonable to focus on the small groups of patients
consuming the majority of resources. However, ‘high-cost
users’ are not a homogenous group. Even when focusing on
a particular patient group that is known to be high-cost, in this
case mental health and addictions, and further refining the
population of interest into persistently high-cost over many
years, heterogeneity in the patient population still occurred.
Despite this potentially heterogeneous study population, and
taking into account other, potentially confounding, factors,
such as healthcare utilization and demographic factors, unsta-
ble housing remained a significant risk factor for persistent
high-cost use.
In terms of public health actions to address housing stabil-
ity, a recent review of the evidence concluded policy makers
should consider providing permanent supportive housing for
homeless/disabled MHA patients (Rog et al. 2014). The pro-
vision of a stable home, particularly for individuals withMHA
and/or complex care needs, not only can decrease healthcare
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Fig. 2 Mental health and
addiction study cohort by total
yearly cost, Saskatoon Health
Region, Saskatchewan, FY 2009–
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Table 2 Average annual cost and healthcare utilization by mental health diagnosis, Saskatoon Health Region, FY 2009–2015 (n = 129,932)
Primary mental health condition n Annual
healthcare cost
Mean (SD); median
Annual
physician visits
Mean (SD)
Annual emergency
department visits
Mean (SD)
Annual
hospitalizations
Mean (SD)
Substance-related disorders 19,201 $1905 ($5253); $502 7 (9) 0.4 (1.4) 0.2 (0.3)
Schizophrenia 5858 $12,488 ($16,080); $5138 15 (13) 0.5 (1.1) 0.4 (0.7)
Mood/affective disorders 36,780 $2251 ($5346); $847 9 (9) 0.3 (0.7) 0.2 (0.3)
Anxiety disorders 67,687 $1765 ($4195); $647 8 (8) 0.3 (0.6) 0.2 (0.3)
Disorders of adult personality 406 $2446 ($6078); $646 9 (12) 0.4 (1.3) 0.2 (0.4)
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Table 3 Regression modelling,
binary distribution, probit link,
comparing persistent high-cost
with not persistently high-cost
use, mental health and addiction
cohort, excluding long-term care
residents, Saskatoon Health
Region, FY2009–2015 (n =
124,497)
Predictor Estimate SE p value
Age 0.002
< 49 years (reference)
≥ 50 years 0.14 0.05
Sex 0.561
Male (reference)
Female 0.03 0.05
Mental health condition < 0.001
Anxiety disorders (reference)
Mood/affective disorders 0.25 0.05
Schizophrenic disorders 0.94 0.07
Substance-related disorders 0.13 0.06
Housing < 0.001
Stable housing (reference)
Unstable housing 0.39 0.07
Comorbid conditions < 0.001
None (reference)
1 0.43 0.04
2 or more 0.92 0.05
Connection to a primary care provider 0.002
Not connected (reference)
Well connected 0.09 0.03
Number of mental health conditions < 0.001
1 (reference)
2 or more 0.29 0.03
Hospitalization(s) < 0.001
No (reference)
Yes 0.54 0.03
Died during study period < 0.001
No (reference)
Yes 1.95 0.05
Connection to a primary care provider*, number of mental health conditions 0.001
Well connected, 2 or more 0.12 0.04
Housing*, comorbid conditions 0.023
Unstable housing, 1 comorbid condition − 0.10 0.12
Unstable housing, 2 or more comorbid conditions − 0.35 0.13
Comorbid conditions*, hospitalization(s) 0.010
1 comorbid, hospitalized − 0.05 0.05
2 or more, hospitalized 0.12 0.05
Comorbid conditions*, died during study period < 0.001
1, died − 0.23 0.06
2 or more, died − 0.38 0.05
Number of mental health conditions*, died during study period < 0.001
2 or more, died − 0.33 0.05
Connection to a primary care provider*, died during study period < 0.001
Well connected, died − 0.64 0.04
Age*, mental health condition < 0.001
≥ 50 years, mood − 0.14 0.06
≥ 50 years, schizophrenia − 0.73 0.10
≥ 50 years, substance-related − 0.19 0.07
Age*, sex 0.993
≥ 50 years, female 0.001 0.06
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utilization/costs, but can improve health outcomes in a vulner-
able population (Dieterich et al. 2017; Fitzpatrick-Lewis et al.
2011; Hwang et al. 2005; Poremski et al. 2016). It may also be
reasonable to consider shifting resources, from costly acute
care for mental health and addiction patients to providing bet-
ter models of care in the community and connection to a
primary care provider, particularly where multiple comorbid
conditions and housing instability are present. A recent
Canadian study demonstrated that community-based, coordi-
nated access to care programs provide improved health out-
comes, cost-effectively, among a cohort of homeless adults
with mental health needs (Stergiopoulos et al. 2018). This
points to the potential to identify mental health clients with
unstable housing and comorbid conditions earlier and offer
‘Housing First’ or other supportive housing services, poten-
tially preventing worsening of both their mental health and
their other comorbidities and increasing their ability to cope
(Chrystal et al. 2015; Poremski et al. 2016).
From published estimates (de Oliveira et al. 2017b, 2016c;
Knapp et al. 2004), we know that schizophrenia and eating
disorders are among the most expensive mental health and
addiction diagnostic categories. In the current study, eating
disorders are not delineated due to privacy considerations of
small numbers in Saskatchewan (< 5 individuals per year);
schizophrenic disorders were the most expensive diagnostic
category.
As ‘high-cost use’ changes over time, even within the same
individual, categories of persistent, sometimes, and never
high-cost were created. Studies describing high-cost use as a
snapshot in time may be combining potentially heterogeneous
categories of individuals. As noted byWodchis et al., one third
of high-cost users in Ontario were found to be persistently
high-cost in the subsequent 2-year study follow-up (Wodchis
et al. 2016); a similar proportion was found in the current
study.
Not surprisingly, we found hospitalization increased the
probability of persistent high-cost use. It is difficult to quantify
‘avoidable’ hospitalizations in administrative health data;
however, a previous study in New Zealand estimated one in
three hospitalizations was avoidable (Jackson and Tobias
2001).
We found that having a good connection to a primary care
provider decreased the probability of being a high-cost user.
Hospitalization is the costliest form of care in the healthcare
system. Efforts to reduce persistent high-cost use could assess
whether or not adequate community-based care could offset
the costs associated with hospitalization(s).
Interestingly, despite accounting for number of days alive
in the study period and excluding long-term care residents in
the modelling, having died during the study period continued
to be a significant risk factor for persistent high-cost use.
Future studies could examine end-of-life costs, particularly if
certain interventions can improve a patient’s experience while
at the same time reducing costs.
This study has several limitations, some inherent to admin-
istrative health databases. By focusing on administrative
health databases, we could not account for all potential con-
founders; for example, food insecurity (Tarasuk et al. 2015)
has been found to be associated with high-cost use but not
available for analysis. Community-based mental health ser-
vice provision (counselling, treatment centres, others) may
be associated with persistent high-cost use but data on these
services were not available for analysis. Our study focused on
cost; however, not all healthcare costs were measured, such as
home care, ambulatory care, out-of-pocket healthcare costs,
such as prescription medication costs covered by private in-
surance, travel costs (air transfers and ground ambulance) and
all indirect costs (caregiving or lost wages). Misclassification
likely occurred when categorizing individuals. For example,
individuals with zero healthcare use and unstable housing
would not be counted, underestimating the number of people
with unstable housing. National data quality processes are in
place for hospitalization and emergency department data;
however, physician billing data can have diagnostic
Table 3 (continued)
Predictor Estimate SE p value
Sex*, mental health condition 0.101
Female, mood − 0.12 0.06
Female, schizophrenia 0.06 0.11
Female, substance-related − 0.12 0.08
Age*, sex*, mental health condition 0.005
≥ 50 years, female, mood 0.18 0.08
≥ 50 years, female, schizophrenia − 0.30 0.14
≥ 50 years, female, substance-related 0.08 0.11
Intercept − 3.09 0.05
Area under the curve = 0.90; Hosmer and Lemeshow goodness-of-fit: χ2 = 11.1; df = 8; p = 0.2
*Disorders of adult personality are included with mood/affective disorders due to small cell sizes (< 5 when
stratified)
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limitations. Despite this, reliability/validity has been found to
be fairly good (Lix et al. 2013).
Results from this study demonstrate that efforts to reduce
persistent high-cost use among a cohort of mental health and
addiction clients should focus on multimorbidity, connection
to a primary care provider (particularly for those with more
than one mental health condition), young patients with schizo-
phrenia, and adequately addressing housing stability.
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